Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Roadmap on plasticity and epigenetics in cancer.
Phys Biol. 2022 Apr 18;19(3):10.1088/1478-3975/ac4ee2. doi: 10.1088/1478-3975/ac4ee2.
Phys Biol. 2022.
PMID: 35078159
Free PMC article.
Review.
Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.
Poels KE, Schoenfeld AJ, Makhnin A, Tobi Y, Wang Y, Frisco-Cabanos H, Chakrabarti S, Shi M, Napoli C, McDonald TO, Tan W, Hata A, Weinrich SL, Yu HA, Michor F.
Poels KE, et al.
Nat Commun. 2021 Jun 17;12(1):3697. doi: 10.1038/s41467-021-23912-4.
Nat Commun. 2021.
PMID: 34140482
Free PMC article.
Clinical Trial.
Item in Clipboard
Author Correction: Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.
Poels KE, Schoenfeld AJ, Makhnin A, Tobi Y, Wang Y, Frisco-Cabanos H, Chakrabarti S, Shi M, Napoli C, McDonald TO, Tan W, Hata A, Weinrich SL, Yu HA, Michor F.
Poels KE, et al.
Nat Commun. 2022 Sep 23;13(1):5579. doi: 10.1038/s41467-022-33355-0.
Nat Commun. 2022.
PMID: 36151107
Free PMC article.
No abstract available.
Item in Clipboard
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.
Starrett JH, Guernet AA, Cuomo ME, Poels KE, van Alderwerelt van Rosenburgh IK, Nagelberg A, Farnsworth D, Price KS, Khan H, Ashtekar KD, Gaefele M, Ayeni D, Stewart TF, Kuhlmann A, Kaech SM, Unni AM, Homer R, Lockwood WW, Michor F, Goldberg SB, Lemmon MA, Smith PD, Cross DAE, Politi K.
Starrett JH, et al. Among authors: poels ke.
Cancer Res. 2020 May 15;80(10):2017-2030. doi: 10.1158/0008-5472.CAN-19-3819. Epub 2020 Mar 19.
Cancer Res. 2020.
PMID: 32193290
Free PMC article.
Item in Clipboard
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia.
Zee BM, Poels KE, Yao CH, Kawabata KC, Wu G, Duy C, Jacobus WD, Senior E, Endress JE, Jambhekar A, Lovitch SB, Ma J, Dhall A, Harris IS, Blanco MA, Sykes DB, Licht JD, Weinstock DM, Melnick A, Haigis MC, Michor F, Shi Y.
Zee BM, et al. Among authors: poels ke.
iScience. 2021 May 25;24(6):102651. doi: 10.1016/j.isci.2021.102651. eCollection 2021 Jun 25.
iScience. 2021.
PMID: 34151238
Free PMC article.
Item in Clipboard
National Trends for Medicare Prescriptions of Antireflux Medications.
Fass OZ, Poels KE.
Fass OZ, et al. Among authors: poels ke.
Gastroenterology. 2020 Jul;159(1):378-380.e3. doi: 10.1053/j.gastro.2020.03.037. Epub 2020 Mar 25.
Gastroenterology. 2020.
PMID: 32222398
No abstract available.
Item in Clipboard
Demographics Predict Stage III/IV Colorectal Cancer in Individuals Under Age 50.
Fass OZ, Poels KE, Qian Y, Zhong H, Liang PS.
Fass OZ, et al. Among authors: poels ke.
J Clin Gastroenterol. 2020 Sep;54(8):714-719. doi: 10.1097/MCG.0000000000001374.
J Clin Gastroenterol. 2020.
PMID: 32520886
Free PMC article.
Item in Clipboard
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
Kim YD, Wang J, Shibli F, Poels KE, Ganocy SJ, Fass R.
Kim YD, et al. Among authors: poels ke.
Aliment Pharmacol Ther. 2021 Sep;54(5):606-615. doi: 10.1111/apt.16464. Epub 2021 Jul 12.
Aliment Pharmacol Ther. 2021.
PMID: 34251045
Item in Clipboard
Cite
Cite